Cadre Holdings, Inc. has announced a significant leadership change as Blaine Browers, the company's Chief Financial Officer (CFO), has decided to resign, effective December 31, 2026. This transition comes at a pivotal time for the company, which operates within the orthopedic, prosthetic, and surgical appliances and supplies sector.
Chad Appleby, who currently serves as the Vice President and Treasurer, will take over as the interim CFO following Browers' departure. Appleby's appointment is effective immediately upon Browers' resignation, and he will continue to serve as the principal financial officer and principal accounting officer during this interim period. This leadership change is crucial as Cadre Holdings continues to navigate the complexities of the financial landscape in its industry.
Background
Cadre Holdings, Inc. is a publicly traded company listed on the New York Stock Exchange under the ticker symbol CDRE. The company is classified under the Standard Industrial Classification (SIC) code 3842, which encompasses orthopedic, prosthetic, and surgical appliances and supplies. Cadre Holdings has been actively involved in providing innovative solutions in this field, and its management decisions are closely watched by industry stakeholders.
What the Filing Says
According to the recent SEC filing, Browers notified the company of his resignation on November 9, 2026. The filing states, "Mr. Browers' resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices." This clarification is important as it reassures stakeholders that the resignation is amicable and not indicative of underlying issues within the company.
In the same filing, the company detailed Appleby's qualifications, noting that he has been with Cadre since October 2014 and previously held the position of Senior Director of Income Tax at PSS World Medical, Inc. Appleby is also a certified public accountant and holds advanced degrees in accounting and taxation.
Impact
This leadership transition may have several implications for Cadre Holdings and its stakeholders. Investors, employees, and customers will be closely monitoring how this change affects the company's financial strategies and operational decisions. The appointment of a seasoned executive like Appleby as interim CFO is expected to provide continuity during the transition period.
Moreover, as Cadre operates in a competitive landscape filled with companies focused on orthopedic and surgical solutions, the ability to maintain financial stability and strategic direction during this interim period will be critical. Competitors may also be observing this transition closely, as changes in leadership can often lead to shifts in market dynamics.
What's Next
The filing does not specify what happens next regarding the search for a permanent CFO or any upcoming votes related to this leadership change. Stakeholders will likely be looking for further announcements from Cadre Holdings in the coming weeks as the company navigates this transition.
Read Next
Lincoln National to Restate Financial Statements Following Error
Freeport-McMoRan plans senior notes offering to refinance debt
Nasus Pharma appoints Nir Sassi as Chief Financial Officer
Cementos Pacasmayo submits revised report on tender offer
Strategy Inc Discloses Key Updates in Recent Filing
Fusion Fuel Green anticipates higher revenue for Q4 2026










